Floatz logo

Therapeutic Asset Ratings

420 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[68Ga]Ga-NOTA-WWH347
Digestive System Cancer
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Digestive System Neoplasm
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Esophageal Cancer
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Gallbladder Carcinoma
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Cancer
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Rectal Cancer
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Small Intestine Cancer
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Gastric Cancer
RenJi HospitalN/AD (30)
bgt007h cell
Pancreatic Neoplasm
RenJi HospitalN/AD (30)
Ciprofol
Intestinal Cancer
RenJi HospitalN/AD (30)
Ciprofol
Intestinal Polyp
RenJi HospitalN/AD (30)
Cyclophosphamide
Portal Vein Thrombosis
RenJi HospitalN/AD (30)
Cyclophosphamide
Radiotherapy; Complications
RenJi HospitalN/AD (30)
Dapagliflozin
Chronic Kidney Disease
RenJi HospitalN/AD (30)
Epirubicin
Liver Transplant; Complications
RenJi HospitalN/AD (30)
Epirubicin
Radiotherapy; Complications
RenJi HospitalN/AD (30)
Henagliflozin
Magnetic Resonance Imaging
RenJi HospitalN/AD (30)
Henagliflozin
Myocardial Fibrosis
RenJi HospitalN/AD (30)
Henagliflozin
Sodium-glucose Co-transporter-2 Inhibitor
RenJi HospitalN/AD (30)
LENVATINIB
Radiation-Induced Disorder
RenJi HospitalN/AD (30)
Letrozole
Abdominal Fat
RenJi HospitalN/AD (30)
Letrozole
Magnetic Resonance Imaging
RenJi HospitalN/AD (30)
Letrozole
Myocardial Fibrosis
RenJi HospitalN/AD (30)
Letrozole
Sodium-glucose Co-transporter-2 Inhibitor
RenJi HospitalN/AD (30)
Showing 326 to 350 of 420 assets
PreviousPage 14 of 17Next